ANG Lifesciences

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE236W01016
  • NSEID:
  • BSEID: 540694
INR
29.00
0.19 (0.66%)
BSENSE

Dec 05

BSE+NSE Vol: 5.62 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
EQUITY AND LIABILITIES
No of Months
12
12
12
12
Share Capital
17.75
17.75
17.75
15.06
Share Warrants & Outstandings
Total Reserve
46.23
58.53
68.47
68.71
Shareholder's Funds
63.98
76.28
86.22
83.77
Minority Interest
0.00
0.00
0.00
0.00
Long-Term Borrowings
18.86
13.95
18.49
21.64
Secured Loans
8.49
12.91
17.35
20.79
Unsecured Loans
10.38
1.04
1.14
0.84
Deferred Tax Assets / Liabilities
-6.37
-3.13
-2.63
-3.67
Other Long Term Liabilities
2.04
2.95
6.14
15.48
Long Term Trade Payables
0.00
2.22
1.97
1.75
Long Term Provisions
1.28
1.14
1.06
1.49
Total Non-Current Liabilities
15.81
17.13
25.04
36.69
Current Liabilities
Trade Payables
66.07
66.18
68.19
70.63
Other Current Liabilities
15.59
22.97
44.56
40.12
Short Term Borrowings
61.57
55.30
49.44
55.36
Short Term Provisions
0.20
0.12
0.09
0.18
Total Current Liabilities
143.44
144.57
162.28
166.29
Total Liabilities
223.22
237.98
273.54
286.75
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
Gross Block
121.61
116.05
143.87
141.97
Less: Accumulated Depreciation
66.88
61.00
58.45
49.36
Less : Impairment of Assets
0.00
0.00
0.00
0.00
Net Block
54.73
55.06
85.42
92.61
Lease Adjustment
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
Non Current Investments
0.03
0.03
0.03
0.03
Long Term Loans & Advances
0.66
0.62
0.52
0.41
Other Non Current Assets
4.31
5.62
1.70
0.88
Total Non-Current Assets
62.19
64.67
90.39
93.93
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
Inventories
54.11
47.77
48.49
36.96
Sundry Debtors
66.54
73.28
83.15
102.06
Cash and Bank
3.64
5.74
6.18
6.65
Other Current Assets
1.14
1.02
1.86
1.40
Short Term Loans and Advances
35.61
45.52
43.48
45.75
Total Current Assets
161.03
173.31
183.15
192.81
Net Current Assets (Including Current Investments)
17.59
28.75
20.87
26.52
Total Current Assets Excluding Current Investments
161.03
173.31
183.15
192.81
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
Total Assets
223.22
237.98
273.54
286.75
Contingent Liabilities
4.05
15.66
16.63
20.30
Total Debt
80.43
69.25
67.94
77.00
Book Value per share (adjusted)
45.4
54.82
62.43
61.024
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 16.14% vs 1.93% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is -30.85% vs -51.95% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is -0.60% vs -35.54% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is -7.09% vs -5.37% in Mar 2024

Compare Balance Sheet Results of ANG Lifesciences
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
17.75
15.83
1.92
12.13%
Share Warrants & Outstandings
Total Reserve
46.23
133.15
-86.92
-65.28%
Shareholder's Funds
63.98
148.98
-85.00
-57.05%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.86
9.23
9.63
104.33%
Secured Loans
8.49
8.70
-0.21
-2.41%
Unsecured Loans
10.38
0.53
9.85
1,858.49%
Deferred Tax Assets / Liabilities
-6.37
9.82
-16.19
-164.87%
Other Long Term Liabilities
2.04
6.80
-4.76
-70.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.28
0.00
1.28
0.00%
Total Non-Current Liabilities
15.81
25.84
-10.03
-38.82%
Current Liabilities
Trade Payables
66.07
91.15
-25.08
-27.52%
Other Current Liabilities
15.59
27.41
-11.82
-43.12%
Short Term Borrowings
61.57
71.94
-10.37
-14.41%
Short Term Provisions
0.20
1.10
-0.90
-81.82%
Total Current Liabilities
143.44
191.60
-48.16
-25.14%
Total Liabilities
223.22
366.42
-143.20
-39.08%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
121.61
269.95
-148.34
-54.95%
Less: Accumulated Depreciation
66.88
122.08
-55.20
-45.22%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
54.73
147.87
-93.14
-62.99%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
2.69
-2.69
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.03
0.00
0.03
0.00%
Long Term Loans & Advances
0.66
2.01
-1.35
-67.16%
Other Non Current Assets
4.31
0.00
4.31
0.00%
Total Non-Current Assets
62.19
167.44
-105.25
-62.86%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
54.11
138.80
-84.69
-61.02%
Sundry Debtors
66.54
39.07
27.47
70.31%
Cash and Bank
3.64
2.59
1.05
40.54%
Other Current Assets
1.14
1.64
-0.50
-30.49%
Short Term Loans and Advances
35.61
16.88
18.73
110.96%
Total Current Assets
161.03
198.98
-37.95
-19.07%
Net Current Assets (Including Current Investments)
17.59
7.38
10.21
138.35%
Total Current Assets Excluding Current Investments
161.03
198.98
-37.95
-19.07%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
223.22
366.42
-143.20
-39.08%
Contingent Liabilities
4.05
34.64
-30.59
-88.31%
Total Debt
80.43
81.33
-0.90
-1.11%
Book Value per share (adjusted)
45.40
89.65
-44.25
-49.36%
Annual - Borrowings
Borrowings 80.43 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.14% vs 1.93% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 2.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -30.85% vs -51.95% in Mar 2024

Annual - Fixed Assets
Fixed Assets 54.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -0.60% vs -35.54% in Mar 2024

Annual - Investments
Investments 0.03 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 161.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -7.09% vs -5.37% in Mar 2024